[Federal Register Volume 73, Number 102 (Tuesday, May 27, 2008)]
[Notices]
[Pages 30418-30419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-11633]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 21, 2007, AMRI 
Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made 
application by renewal to the Drug Enforcement Administration (DEA) as 
a bulk manufacturer of the basic classes of controlled substances 
listed in schedules I and II:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)..........................                             I
Tetrahydrocannabinols (7370)..............                             I
Amphetamine (1100)........................                            II
Lisdexamfetamine (1205)...................                            II
Methylphenidate (1724)....................                            II
Pentobarbital (2270)......................                            II
Hydrocodone (9193)........................                            II
Meperidine (9230).........................                            II
Dextropropoxyphene, bulk (non-dosage form)                            II
 (9273)...................................
Oxymorphone (9652)........................                            II
Fentanyl (9801)...........................                            II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers. In 
reference to drug code 7360 (Marihuana), the company plans to bulk 
manufacture cannabidiol as a synthetic intermediate. This controlled 
substance will be further synthesized to bulk

[[Page 30419]]

manufacture a synthetic THC (7370). No other activity for this drug 
code is authorized for this registration.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than July 28, 2008.

    Dated: May 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-11633 Filed 5-23-08; 8:45 am]
BILLING CODE 4410-09-P